SEP-631

· Septerna, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SEP-631, covering 2026-04-21 to 2026-04-21. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate Single and Multiple Doses of SEP-631 in Healthy Adult Volunteers [Phase 1]